Skip to main content
December 2021 - January 2022
CURRENT ISSUE
AAM Magazine
Dec 2021 - Jan 2022
Back to November 2021

Transition at KKR

By Paul Mackintosh   
  • Asia
  • Global
  • USA
I’ll leave off commenting on prospects for the potential US$54 billion bid for GlaxoSmithKline Plc’s consumer unit by putative suitors, including Advent International, Blackstone Inc., Carlyle Group Inc., CVC Capital Partners, KKR &...

To continue reading this article, you need a subscription to view this article.
Log in below or buy a subscription to enjoy unlimited access to www.asiaasset.com's quickly growing 7,000 article database.